Phibro Animal Health Co. (NASDAQ:PAHC) Declares $0.12 Quarterly Dividend

Phibro Animal Health Co. (NASDAQ:PAHC) announced a quarterly dividend on Tuesday, November 5th,Zacks Dividends reports. Shareholders of record on Wednesday, November 27th will be given a dividend of 0.12 per share on Wednesday, December 18th. This represents a $0.48 annualized dividend and a yield of 1.99%. The ex-dividend date is Wednesday, November 27th.

Phibro Animal Health has a dividend payout ratio of 31.2% indicating that its dividend is sufficiently covered by earnings. Analysts expect Phibro Animal Health to earn $1.90 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 25.3%.

Phibro Animal Health Stock Up 2.2 %

PAHC opened at $24.14 on Tuesday. Phibro Animal Health has a 12 month low of $9.49 and a 12 month high of $25.98. The company has a market cap of $977.67 million, a PE ratio of 56.14, a price-to-earnings-growth ratio of 0.61 and a beta of 0.51. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. The company has a 50 day moving average of $23.22 and a 200 day moving average of $20.07.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. The firm had revenue of $273.16 million during the quarter, compared to analyst estimates of $262.44 million. On average, sell-side analysts expect that Phibro Animal Health will post 1.61 EPS for the current year.

Insiders Place Their Bets

In related news, Director E Thomas Corcoran acquired 5,000 shares of the company’s stock in a transaction dated Wednesday, September 4th. The stock was bought at an average cost of $20.02 per share, with a total value of $100,100.00. Following the acquisition, the director now owns 25,000 shares of the company’s stock, valued at approximately $500,500. The trade was a 25.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 50.07% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on PAHC. JPMorgan Chase & Co. started coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target on the stock. Barclays increased their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, November 20th. Finally, Bank of America increased their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $16.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.